AMENDMENTS TO THE MSA. Section 2.1 Amendment to Schedule 1. Effective as of the date hereof, Section 1.1 of Schedule 1 of the MSA shall be amended to add the following defined terms in alphabetical order:
AMENDMENTS TO THE MSA. (a) Section 2.1 of the MSA shall be amended to add Section 2.1.3 as follows:
AMENDMENTS TO THE MSA. 2.1 Schedule 1 of the MSA is amended to add the following additional countries: “Algeria, Angola, Bahrain, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Congo, Cote D’Ivoire, Democratic Republic of the Congo, Djibouti, Egypt, Equitorial Guinia, Eritria, Ethiopia, Gabon, Ghana, Guinia, Iran, Iraq, Jordan, Kenya, Kuwait, Lebanon, Lesotho, Libya, Madagascar, Malawi, Mali, Mauritius, Morocco, Mozambique, Namibia, Nigeria, Oman, Qatar, Rwanda, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Somalia, , South Sudan, Sudan, Swaziland, Tanzania, Togo, Tunisia, U.A.E, Uganda, Yemen, Zambia, Zimbabwe” In WITNESS WHEREOF the PARTIES hereto have caused this AMENDMENT to be executed in duplicate by their duly authorized officers as of the Commencement Date. HORIZON PHARMA AG MUNDIPHARMA MEDICAL COMPANY By: /s/ Xxxxxx X. Xxxx By: /s/ Xxxxxxx Xxxxxxxx Name: Xxxxxx X. Xxxx Name: Xxxxxxx Xxxxxxxx Title: SVP Business Ops Title: General Manager HORIZON PHARMA AG By: /s/ Xxxxxxx X. Xxxxxxx Name: Xxxxxxx X. Xxxxxxx Title: Chairman, President and CEO
AMENDMENTS TO THE MSA a. Section 3.6. The last sentence of Section 3.6 is hereby deleted in its entirety and replaced with the following: “If Customer chooses to terminate under this Section 3.6, the effective termination date shall be one hundred eighty (180) days after Customer provides notice of termination.”
AMENDMENTS TO THE MSA. 2.1 Section (b)
AMENDMENTS TO THE MSA. 2.1 Schedule 1 of the MSA is amended to add the following additional countries: “Cambodia, Myanmar, Laos and Brunei.”
AMENDMENTS TO THE MSA. 2.1 Schedule 1 of the MSA is amended to add the following additional countries: “Mexico, Brazil, Argentina, Colombia, Venezuela, Peru, Chile, Ecuador, Dominican Republic, Guatemala, Costa Rica, Uruguay, Bolivia, Panama, Nicaragua, El Salvador and Honduras.”
AMENDMENTS TO THE MSA. (a) Section 2.1 of the MSA shall be amended to add Section 2.1.3 as follows: 2.1.3 iCell® commercial induced pluriopotent stem cell derived cell types. (b) Section 28.1 shall be amended to add the following: 1 (****) DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE U.S.
AMENDMENTS TO THE MSA. 1. All references in the MSA to “CRRA” shall refer to the Authority. All capitalized terms used but not defined herein have the meanings in the MSA.
